Vitamin Shoppe (VSI) Tops Q4 EPS by 10c, Offers Outlook

Vitamin Shoppe (NYSE: VSI) reported Q4 EPS of ($0.19), $0.10 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $248.5 million versus the consensus estimate of $253.1 million.

2019 Outlook

The Company is providing guidance around the key levers that drive the business. Specifically:

• Full year comparable sales of negative low single digits to flat
• Reported full year gross margin rate of 31.7% to 32.2%.
• Adjusted EBITDA of $62 million to $65 million.
• Estimated combined Federal, State and Local tax rate of 28%.
• Full year capital expenditures of approximately $33 million, and includes the opening of approximately 10 new stores.
• Closing approximately 60 to 80 stores over next three years

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Reading (RDI) Tops Q2 EPS by 4c